Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-06

Clinical Trial Update: The Indol Profile; Exploring the Metabolic Profile of Neuroendocrine Tumors

View source ↗

Summary

This entry notes the completion of a clinical trial exploring the metabolic profile of neuroendocrine tumors under the Indol Profile program. Sponsor and status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Medical Center Groningen | Conditions: Neuroendocrine Tumors | Status: COMPLETED